Bioequivalence and Bioavailability Forum

Question about Treatment Effect jag009 2013-08-13 23:30
- significant ≠ relevant Helmut 2013-08-14 00:53

Geometric mean of normal dist etc. ElMaestro 2013-08-07 13:18
- Geometric mean of normal dist etc. Helmut 2013-08-07 16:20
  - Geometric mean of normal dist etc. ElMaestro 2013-08-07 16:28
    - Overheated brain Helmut 2013-08-07 16:37
    - Location parameters Helmut 2013-08-08 13:10
      - Location parameters ElMaestro 2013-08-08 13:52
        
        Distribution of concentrations Helmut 2013-08-08 14:35

3 way ABE Stat Model nasir 2013-08-03 16:30
- 3 way ABE Stat Model jag009 2013-08-03 22:54
  - 3 way ABE Stat Model nasir 2013-08-06 00:52

Does anyone knows about 50-50 MANOVA?? im.sagark 2013-07-29 13:29

CV after log10-transformation Helmut 2013-07-15 17:40
- CV after log10-transformation yjlee168 2013-07-15 19:38
  - CV after log10-transformation Helmut 2013-07-15 20:37

Cross over Design with Three treatments sandeep reddy 2013-07-09 10:57
- BIBD? d_labes 2013-07-09 11:55

F values in ANOVA table Ken Peh 2013-07-01 18:17
- F values in ANOVA table Ohlbe 2013-07-01 18:40
  - F values in ANOVA table Ken Peh 2013-07-02 09:47
- F values in ANOVA table ElMaestro 2013-07-01 20:24
  - F values in ANOVA table Ken Peh 2013-07-02 09:49

Hypothesis in Bioequivalence Studies udayk 2013-06-21 09:35
- Hypotheses in Bioequivalence Studies Helmut 2013-06-21 13:51
  - Management's null hypothesis ElMaestro 2013-06-21 14:20

BE and gender AngusMcLean 2013-06-11 20:17
- BE and gender ElMaestro 2013-06-11 20:47
- BE and gender Dr_Dan 2013-06-12 09:57
  - BE and gender (recent lenghty example) Helmut 2013-06-12 13:45
  - BE and gender AngusMcLean 2013-06-15 15:10

Mathematical Expression for Sum of Squares im.sagark 2013-06-07 10:30
- Yes, we understand Helmut 2013-06-07 11:26

Sum of squares for Unbalanced 3X3 crossover Design im.sagark 2013-06-06 09:16
- SS, Unbalanced 3X3 crossover Design ElMaestro 2013-06-06 11:13
  - SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 11:20
    - SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 11:31
      - SS, Unbalanced 3X3 crossover Design Dr_Dan 2013-06-06 12:21
        
        SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 13:38
  - SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 11:45
    - SS, Unbalanced 3X3 crossover Design ElMaestro 2013-06-06 12:06
      - SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 12:27
        
        SS, Unbalanced 3X3 crossover Design ElMaestro 2013-06-06 12:55
        
        SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-06 13:17
        
        SS, Unbalanced 3X3 crossover Design ElMaestro 2013-06-06 17:25
        
        SS, Unbalanced 3X3 crossover Design im.sagark 2013-06-07 05:54

Tmax, ke and t1/2 in fully replicate design of HVD Ken Peh 2013-05-21 19:24
- No stats Helmut 2013-05-22 20:54
  - No stats Ken Peh 2013-05-23 11:44
    - No stats Helmut 2013-05-23 12:03

Impact of dosing scheme on stats jag009 2013-05-22 15:33
- Impact of dosing scheme on stats ElMaestro 2013-05-22 16:12

Power calculation from Partial replicate study jag009 2013-05-16 16:18

Elementary question on HVD datasets jag009 2013-05-15 22:57
- No. 1 Helmut 2013-05-16 01:32
  - No. 1 jag009 2013-05-16 15:57

Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
160 visitors (0 registered, 160 guests [including 43 identified bots]).
Forum time: 01:38 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking. Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz